IP Verse

Richter Gedeon Nyrt competitive analysis

Latest oppositions filed by Richter Gedeon Nyrt

Explore patent oppositions filed by Richter Gedeon Nyrt against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
EP2055313
Treatment Of Hematologic Malignancies Associated With Circulating Tumor Cells Using Chimeric Anti-Cd20 AntibodyBIOGENOct 13, 2015
EP1951304
Method For Treating Joint DamageBIOGEN IDECJul 21, 2015

Latest patents of Richter Gedeon Nyrt opposed by its competitors

Explore Richter Gedeon Nyrt's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3877395
Dec 7, 2022Industrial Process For The Preparation Of High Purity Estetrol1
EP2925324
Dec 30, 2020Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia2
EP2828396
Apr 24, 2019Method For The Production Of Polypeptides1
EP3212667
Sep 19, 2018Pharmaceutical Anti-Tnf-Alpha Antibody Formulation3
EP2673282
Nov 9, 2016Novel Process For The Preparation Of Dronic Acids1

Latest PTAB cases involving Richter Gedeon Nyrt

Discover the latest PTAB cases involving Richter Gedeon Nyrt, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Richter Gedeon Nyrt with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
RICHTER GEDEON NYRT28 - -
BIOGEN68 - 12
BIOGEN IDEC - 17 - -
F HOFFMANN LA ROCHE34231 - -